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Abstract Glioblastoma is a rapidly evolving high-grade astrocytoma that is
distinguished pathologically from lower grade gliomas by the presence of necro-
sis and microvascular hiperplasia. Necrotic areas are typically surrounded by
hypercellular regions known as pseudopalisades originated by local tumor ves-
sel occlusions that induce collective cellular migration events. This leads to the
formation of waves of tumor cells actively migrating away from central hypoxia.
We present a mathematical model that incorporates the interplay among two
tumor cell phenotypes, a necrotic core and the oxygen distribution. Our simu-
lations reveal the formation of a traveling wave of tumor cells that reproduces
the observed histologic patterns of pseudopalisades. Additional simulations of
the model equations show that preventing the collapse of tumor microvessels
leads to slower glioma invasion, a fact that might be exploited for therapeutic
purposes.
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1 Introduction
Malignant gliomas are the most common and lethal type of primary brain
tumor. Survival for patients with glioblastoma multiforme (GBM), the most
aggressive and prevalent WHO grade IV astrocytic glioma (Louis et al. 2007;
Wen and Kesari 2008), although individually variable, is about 12 months after
diagnosis, using the standard of care which includes surgery to resect as much
tumoral tissue as possible, radiotherapy and chemotherapy (temozolamide)
(Huse and Holland 2010; Van Meir et al. 2010; Clarke et al. 2010; Reardon et
al. 2011; Pruitt et al. 2011). GBM is a rapidly evolving astrocytoma that is dis-
tinguished pathologically from lower grade gliomas by the presence of necrosis
in the central regions of the tumor and microvascular hyperplasia (Louis et al.
2007). Another distinctive signature of GBM is the fact that necrotic foci are
frequently surrounded by hypercellular regions known as pseudopalisades. An
example of these hypercellular perinecrotic structures is shown in Figure 1.
The fact that GBM is one of the most highly vascularized human tumors
seems to contradict that its microcirculation is functionally very inefficient
(Jensen 2009). However, it is well known that the tumor microenvironment is
remarkably different from that of normal tissue; its chaotic vasculature leads
both to a decrease in the supply of oxygen and essential nutrients as well as
in the removal of waste products.
Tumor hypoxia (deficit in oxygenation) is a feature encountered in most
solid tumors (Semenza et al. 2003; Vaupel 2008; Bristow and Hill 2008; De-
whirst et al. 2008), albeit with an incidence and severity that varies among
patients. It is generally recognized as a negative clinical prognostic and predic-
tive factor owing to its involvement in various cancer hallmarks such as resis-
tance to cell death, angiogenesis, invasiveness, metastasis, altered metabolism
and genomic instability (Hanahan and Weinberg 2011; Wilson and Hay 2011).
Hypoxia displays a central role in tumor progression and resistance to ther-
apy (chemo- and radioresistance), specially in GBM (Jensen 2009; Pope et al.
2011). Low oxygen levels are observed both in the near vicinity of the tumor
vasculature, as acute or cycling hypoxia (Bristow and Hill 2008; Dewhirst et
al. 2008), or at longer distances of about 150 µm from the feeding blood vessels
giving rise to areas of chronic or diffusion-limited hypoxia (Bristow and Hill
2008). Angiogenesis emerges then in response to the imbalance of proangio-
genic growth factors that are released by hypoxic cells in the tumor such as
vascular endothelial growth factor (VEGF) relative to anti-angiogenic growth
factors (e.g., angiostatin) present in the tumor microenvironment (Carmeliet
and Jain 2011; Ebos and Kebel 2011). The end result of VEGF signaling in tu-
mors is the production of immature, highly permeable blood vessels with sub-
sequent poor maintenance of the blood brain barrier and parenchymal edema
(Jain et al. 2007). Thus, microvascular hyperplasia may coexist with moderate
or high levels of hypoxia. Actually, for GBM it has been shown that microvas-
cular hyperplasia is spatially and temporally associated with pseudopalisading
necrosis and is believed to be driven by hypoxia-induced expression of proan-
giogenic cytokines such as VEGF (Rong et al. 2006).
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Fig. 1 Pseudopalisading structures in Glioblastoma Multiforme. This histopatho-
logic sample shows the typical features of pseudopalisades in GBM. Hypercellular regions
appear around centrally degenerating vessels (star). The standard interpretation (Brat et
al. 2004) is that cells migrate away from the degenerated vessels (hypoxic) areas and move
towards functional vascular supplies such as the one marked with an arrow head in the
photograph.
In general, GBMs are pathologically heterogeneous with central regions of
necrosis surrounded by pseudopalisading cells and hypervascularized regions
under moderate levels of hypoxic stress (Gorin et al. 2004). In addition, the
periphery of the GBM typically shows tumor cells infiltrating into the nor-
mal brain. This invasion often extends to the adjacent cortex and through
the corpus callosum into the contralateral hemisphere, being a major reason
for treatment failure: migrating cells are not eliminated by surgical resection
and cause tumor recurrence (Onishi et al. 2011). Thus, high grade astrocytic
tumors typically recur in less than six months after surgery (Giese et al. 2003).
Emerging evidence from clinical observations suggests that the origin of
pseudopalisade formation is a vaso-occlusive event where the local blood ves-
sels no longer provide the necessary oxygen supply to the tumor microenviron-
ment, resulting in a population of migrating hypoxic cells responsible for the
formation of the pseudopalisades (see Figure 1). Establishing a clear mecha-
nism underlying pseudopalisade formation and its role in necrosis is critical
since their formation could potentially precede all forms of coagulative necrosis
in GBM (Brat and Van Meir 2004; Brat et al. 2004), responsible for the broad
necrotic areas detected, for example, by standard magnetic resonance imaging
of brain tumors. In fact, pathologic examinations indicate that hypoxia and
necrosis development within high grade astrocytomas could arise secondary
to vaso-occlusion. Pseudopalisades would then represent a wave of tumor cells
migrating away from central hypoxia (Rong et al. 2006).
Experimental studies have hypothesized that pseudopalisade formation
could provide a mechanism accounting for the rapid clinical progression of
GBM, acting as a link among the underlying vascular damage, the develop-
ment of hypoxia and hypoxia-induced angiogenesis, leading to necrosis and
4 Alicia Mart´ınez-Gonza´lez et al.
Fig. 2 Glioblastoma microenvironment modeled in this work. The system modeled
consists of two blood vessels and an evolving embedded population of tumor cells whose phe-
notype changes according to the levels of oxygenation. Upon thrombosis of one of the blood
vessels (the right one), due to excessive tumor cell growth and the secretion of thrombotic
factors, decreasing levels of local oxygenation arise that promote a massive migration of
hypoxic glioma cells (labeled as II) towards better oxygenated areas. In the process, the hy-
poxic glioma cells infiltrate among the normoxic glioma cells (labeled as I), which are closer
to a functional vessel (the left one), creating a transient hypercellularity region (a pseu-
dopalisade). As the pseudopalisading front of glioma cells enlarges around the thrombosed
vessel, perivascular necrosis becomes more prominent.
accelerated outward tumor expansion in the form of a migrating wave of cells.
Previous works have proposed that pseudopalisade formation would be the
result of a multistep process (Brat et al. 2004; Rong et al. 2006; Brat and
Van Meir 2004): First, in anaplasic astrocytoma (WHO grade III) or de novo
GBM in its initial stages, tumor cells proliferate and infiltrate through the
parenchyma and receive oxygen and nutrients via the intact native blood ves-
sels. Secondly, vascular insult occurs as a result of uncontrolled tumor growth
causing endothelial injury and vascular leakiness. Both endothelial injury and
the expression of procoagulant factors by the neoplasm result in intravascu-
lar thrombosis and increasing hypoxia in the regions surrounding the vessel
(Rahman et al. 2010). Subsequently, tumor cells begin to migrate away from
hypoxia, creating a peripherally moving wave that is seen microscopically as
pseudopalisading cells. This leads to an expansion of the zone of hypoxia and
central necrosis, whereas the hypoxic tumor cells in pseudopalisades secrete
proangiogenic factors (e.g. cytokines VEGF and IL-8).
In this work we study the formation of hyper cellular regions in perinecrotic
areas in high grade gliomas. We put forward a mathematical model that incor-
porates the spatio-temporal interplay among two tumor cell phenotypes corre-
sponding to well oxygenated (normoxic) and hypoxic cells, a necrotic core and
the oxygen distribution. Our physio-pathologic scenario is depicted in Figure
2 and consists of a tumor cell population embedded within two blood vessels
arranged in a flat domain. Our numerical simulations reveal the formation of
a superimposed traveling wave of hypoxic cells that qualitatively reproduces
the experimentally observed patterns and may be used to obtain some hints
for the timescales of palisade formation, lifetime and persistence among other
Cell Waves around Necrotic Cores in GBM 5
prognostic metrics. We also explore the dynamics of tumor spreading under
delayed vascular injury and show that somehow, contrary to naive intuition, in
the framework of our model preventing vessels from breaking leads to slower
tumor invasion speeds that might be explored for therapeutic purposes.
2 The Model
2.1 Glioblastoma compartment dynamics
Our modeled system comprises three different compartments; two different
coupled tumor cell subpopulations corresponding to the two dominant phe-
notypes well described in GBM (DeBerardinis et al. 2007; Giese et al. 2003;
Keunen et al. 2011; Onishi et al. 2011) and a necrotic compartment. Of the two
populations, the first one, Cn, consists of normoxic, proliferative, less mobile
cells (typically located close to functional blood vessels), whereas the second
one, Ch, is composed of hypoxic, less proliferative and more mobile cells. Both
phenotypes compete for space and resources (in our case oxygen). The cell
loss is included in a third compartment, Cd, of necrotic tissue. The equations
governing the interplay among these three densities are as follows
∂Cn
∂t
= Dn∇2Cn + 1
τn
(
1− Cn + Ch + Cd
C(M)
)
Cn +
1
τhn
ShnCh
− 1
τnh
SnhCn, (1a)
∂Ch
∂t
= Dh∇2Ch + 1
τh
(
1− Cn + Ch + Cd
C(M)
)
Ch − 1
τhn
ShnCh
+
1
τnh
SnhCn − 1
τhd
ShdCh, (1b)
∂Cd
∂t
=
1
τhd
ShdCh. (1c)
The first terms in Eqs. (1a) and (1b) account for the cellular motility. Migra-
tion in gliomas is not simple and in fact many have proposed that the highly
infiltrative nature of human gliomas recapitulates the migratory behavior of
glial progenitors (Suzuki et al. 2002; Dirks 2001). Here we assume, as in most
models (Frieboes et al. 2007; Swanson et al. 2008; Bondiau et al. 2008; Eiken-
berry et al. 2009; Konukoglu et al. 2010; Rockne et al. 2010; Pe´rez-Garc´ıa et
al. 2011), that glioma cell invasion throughout the brain is basically governed
by a standard Fickian diffusion process.
It is believed that glioma cells -as many other types of cells- do not move
and proliferate simultaneously (Giese et al. 2003). This is referred to as the mi-
gration/proliferation dichotomy and leads to the fact that highly motile cells
should exhibit low proliferation rates. The switch between proliferative and
invasive phenotype cannot be only mutation driven (Hatzikorou et al. 2010;
Onishi et al. 2011) and it has been suggested that invasive glioma cells are
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able to revert to a proliferative cellular program and vice versa, depending on
the environmental stimuli (Giese et al. 2003; Keunen et al. 2011). Recently,
it has been proposed that oxygen concentration may be one of those stim-
uli able to drive this transformation and thus for each oxygen level, there
exists a dominant (fittest) tumor cell phenotype that corresponds to certain
ratio proliferation/migration rates (Giese et al. 2003). Several studies have
linked hypoxia to the invasive behavior of different types of tumors and their
relationship with metastasis and negative prognosis (Bristow and Hill 2008;
Kalliomaki et al. 2009; Elstner et al. 2007). Mathematically, the observation
that the hypoxic phenotype is more migratory than the normoxic one (Berens
and Giese 1999; Giese et al. 2003; Bristow and Hill 2008; Gorin et al. 2004)
translates to choosing the hypoxic cell diffusion coefficient Dh to be larger
than the normoxic one Dn.
The second terms in Eqs. (1a) and (1b) employ a classical logistic growth
for the tumor cell populations with proliferation times τn and τh, respectively.
Thus, the net proliferation is lower in regions of high cell density where Cn +
Ch + Cd is close to the maximum density capacity C
(M), than in regions of
low cell density where Cn + Ch + Cd is much smaller than C
(M). As to the
parameters τn and τh, the migration-proliferation dichotomy suggests that
τn < τh. Since growth is assumed to be space-limited we incorporate also the
necrotic tissue density into the saturation terms.
The third terms in Eqs. (1a) and (1b) are essential ingredients of our model
since they represent the phenotypic switch under the effect of changing mi-
croenvironmental conditions. The switch functions Snh, Shn depend on the
oxygen concentration (to be specified below) and account for the fact that
under low oxygen conditions normoxic cells change their phenotype to the hy-
poxic one with a rate 1/τnh, whereas when exposed to sufficiently high oxygen
concentrations hypoxic cells recover their oxic phenotype with a rate 1/τhn.
Equations (1) also include hypoxic cell loss by death due to anoxia [cf.
last term in Eq. (1b)] and how these lost cells feed the necrotic tissue [cf. Eq.
(1c)]. The last term in Eq. (1b) represents (anoxic) cells dying when the oxy-
genation conditions are adverse enough as measured by the switch function
Shd, with a rate 1/τhd. It should be emphasized that cell loss in glioma occurs
both by apoptosis (representing death by controlled suicide) and by necro-
sis (death by uncontrolled damage). Necrosis has historically been considered
to be an inappropriate or accidental death that arises under conditions that
are extremely unfavorable such as those incompatible with a critical normal
physiological process. More recently, a number of studies have suggested that
necrosis is also a regulated process that can be modulated. For example, in-
duction of necrosis seems to be dependent on cellular energy stores, such as
NAD and ATP. Furthermore, cell stress and cell signaling including oxidative
stress, calcium levels and p53 activation have been shown to influence lyso-
somal membrane permeability and survival (Boya and Kroemer 2008). When
apoptosis sets in, the cell membrane collapses and the cell shrinks, while when
necrosis occurs the cell keeps its shape and thus still occupies a physical space
(Hotchkiss et al. 2009). This leads to the fact that cell loss due to apoptosis,
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not leading to the fill up of space, can be simply incorporated into effective
proliferation cell rates in Eqs. (1a) and (1b). However, cell death by necrosis
happens at a different rate and, in addition, results in occupied space; this
is the reason for incorporating the population Cd into the proliferation lim-
iting terms in Eqs. (1a) and (1b). Overall, levels of apoptosis are generally
low in malignant gliomas; apoptosis accounting for only a slim minority of cell
death. Furthermore, apoptotic rates do not correlate with prognosis (Migheli
et al. 1994; Schiffer et al. 1995). In contrast, coagulative necrosis represents the
majority of cell death in GBMs and its degree is inversely related to patient
survival, as several shown by Nelson et al. (1983) and Lacroix et al. (2001).
2.2 Microenvironment oxygenation
Though the GBM microenvironment is highly heterogeneous at the cellular
and molecular levels (Bonavia et al. 2011), two of the main chemical agents
implicated in its growth and metabolism are oxygen and nutrients, mainly
glucose and lactate (Mendoza et al. 2011; Griguer et al. 2005, 2008; Seyfried
et al. 2011). A more comprehensive description of the GBM microenvironment
should, a priori, take into account the interplay not only of oxygen but of nu-
trients as well, at the expense of increasing the complexity of the mathematical
model. Here we show that it suffices to take oxygen as the key chemical agent
driving the collective cell migration dynamics to understand pseudopalisade
formation in GBM. Moreover, glucose is typically less scarce than oxygen even
at long distances from the blood vessels and can be replaced by other fuels
such as lactate or, in a smaller fraction, by pyruvate, malate or glutamine (De-
Berardinis et al. 2007; Mendoza et al. 2011; Beckner et al. 2005; Grillon et al.
2011). For instance, sequestration of lactate and pyruvate in the extracellular
matrix has been observed in C6 gliomas in a rat brain by Grillon et al. (2011)
and correlates with the persistent acidity of the GBM microenvironment.
Oxygen tissue heterogeneities are recognized to be a very relevant factor in
gliomas and many other tumor types (Evans et al. 2004). The spatio-temporal
variation of oxygen distribution, driving the presence of various phenotypic
tumor subpopulations, would help to explain the diversity of responses ob-
tained from the same treatment employed in patients with apparently similar
tumors but irrigated in a different way. Here, a Michaelis-Menten type kinetics
is used for the uptake of oxygen (Patel et al. 2001; Ferreira et al. 2002), but
now encompassing the feedback by the normoxic and hypoxic cells
∂O2
∂t
= DO2∇2O2 −
αnCn + αhCh
O
(T )
2 +O2
O2. (2)
The first term in Eq. (2) accounts for the oxygen diffusion in the brain tissue
assuming a homogenous and isotropic diffusion coefficient DO2 for simplic-
ity. Although oxygen passes successively through the intracellular fluid, cell
membranes and cytoplasm, all having abrupt spatial variations, employing an
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Fig. 3 Oxygen concentration influences the phenotype of a tumor cell. Depending
on the oxygen concentration various switching mechanisms arise coupling the populations:
Normoxic to hypoxic, Snh, hypoxic to normoxic Shn and hypoxic to necrotic Shd. High
oxygen levels favor the existence of more proliferative phenotypes which are less mobile.
On the contrary, cells respond to low oxygen concentrations by expressing less proliferative
phenotypes which are more motile, and finally, hypoxic cells experiencing persistent anoxia
will eventually die (Brat et al. 2004).
average diffusion coefficient for oxygen has been proven to be a good approxi-
mation in previous works (Tannock 1972; Pogue et al. 2001). The second term
models the oxygen consumption by normoxic and hypoxic cells at rates αn and
αh, respectively. The saturation Michaelis-Menten constant O
(T )
2 corresponds
to the oxygen concentration level at which the reaction rate is halved.
When modeling the oxygenation dynamics, we will assume that normoxic
cells switch to the hypoxic phenotype with a characteristic time τnh when the
local oxygen concentration is below a critical value O
(S)
2 , such that hypoxia-
inducible factor 1α (HIF-1α) is not degraded and the glycolytic and angiogen-
esis mechanisms initiate (Jewell and Gassmann 2001). The switching of cells
from the hypoxic to the normoxic state Shn, as described by Eqs. (1a) and
(1b), occurs with a characteristic time τhn and is a reversible process Snh; if
the local oxygen sensed by a hypoxic cell is above O
(S)
2 , the cell will undergo a
phenotypic switch to the normoxic state (as it satisfies O2 > O
(S)
2 ) and vicev-
ersa. Finally, hypoxic cells experiencing persistent anoxia will eventually die
when the oxygen concentration is below a threshold value O
(D)
2 with a charac-
teristic time τhd. The specific form of the three step-like switch functions are
Shn(O2) =
1
2
[
1 + tanh
(
O2 −O(S)2
∆O2
)]
, (3a)
Snh(O2) =
1
2
[
1− tanh
(
O2 −O(S)2
∆O2
)]
, (3b)
Shd(O2) =
1
2
[
1− tanh
(
O2 −O(D)2
∆O2
)]
. (3c)
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The extra parameter ∆O2 accounts for the fact that transitions occur around
the critical values O
(S)
2 and O
(D)
2 with a characteristic range (or width). In our
calculations we have taken the same small width ∆O2 for all of the transitions.
The change from the hypoxic state to necrosis is irreversible and takes place
in an interval centered around O
(D)
2 , the size of this transition domain being
proportional to ∆O2.
Although it is possible to incorporate the oxygen supply by resorting to
extra source functions, here we will use a more direct approach and oxygen
will be provided initially through the two capillaries located at the boundaries
of the tumor domain (see Figure 2). As soon as one of the two blood vessels
becomes impaired by a thrombus, the remaining functional one will be the
sole source of oxygen.
2.3 Parameter estimation
We resort to available experimental values from human glioma models to ob-
tain order-of-magnitude estimates of the intervening parameters in our equa-
tions. First, the maximum cell density C(M) has been estimated in previous
works (see e.g. Rockne et al. 2010) to be of about 106 cell/cm2. The oxygen
concentration at which cells switch to hypoxic metabolism depends on the
specific cell line but experimental evidences support for glioma the choice of 7
mm Hg (Vaupel 2004). The Michaelis-Menten constant has to be smaller than
this value yet larger than the anoxia threshold of about 0.7 mm Hg (Brown
and Wilson 2004). We have chosen it to be about O
(T )
2 = 2.5 mm Hg (Dac¸u
et al. 2003; Wilson 2008).
For the oxygen consumption parameters, although there is a high variabil-
ity between different cell lines, we will take the values of U251 glioma cells
from Griguer et al. (2008). As to the hypoxic oxygen consumption, this is a
parameter difficult to assess. We will use data for the same cell line U251 but
genetically modified to deplete its mitochondrial DNA so that the cell’s oxida-
tive capacity is virtually impaired. Data from Griguer et al. (2008) indicates
that the normoxic cell uptake is five times higher than the hypoxic cell con-
sumption. We have indeed assumed that the consumption rates were reported
for normal conditions of pressure and temperature. Moreover, it is known that
the mean oxygen pressure in arterial blood is around 95 mm Hg (Kimura et
al. 1996), while venous values are around 30-40 mm Hg (Wilson 2008) thus,
we will take the oxygen pressure at our boundary capillaries to be Ovi2 = 60
mm Hg.
The oxygen diffusion coefficient is classically known to be around 10−5
cm2/s (Muelller-Klieser et al. 1984) while the cell diffusion coefficients are
not so readily accessible to obtain in vivo. We resort to the data from Wang
et al. (2009), were the authors have exploited a recently developed tool for
quantifying glioma net invasion rates in individual patients using routinely
available magnetic resonance images (MRI) from 32 patients to derive a net
measure of the invasive capacity of the overall dominant phenotype. Since
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they obtain the parameters for the invasive phenotype, which is the most
migratory one, and this is linked to the hypoxic one in our model, we will take
their median migration rate 29 mm2/year as our fast diffusion coefficient for
hypoxic cells. The normoxic cell diffusion will be taken to be smaller than the
hypoxic one, in our case Dn = 0.1Dh.
Finally, the proliferation parameters can be estimated from typical dou-
bling times that range from 24 to 48 h for glioma cells in vitro for well oxy-
genated cells, while the mobile hypoxic cells doubling times are assumed to be
longer (we have taken this parameter to range within two to four times the
previous one). Table 1 summarizes the typical parameter values employed in
our calculations.
Table 1 Values of the biological parameters used into our model equations.
Variable Description Value References
C(M) Maximum tumor 106 cell/cm2 (Rockne et al. 2010)
cell density
O
(S)
2 Oxygen concentration 7 mmHg (Vaupel 2004)
switch to hypoxia
O
(T )
2 Michaelis Menten 2.5 mmHg (Dac¸u et al. 2003)
oxygen threshold
O
(D)
2 Oxygen level 0.7 mmHg (Brown and Wilson 2004)
for anoxia
O
vi
2 i=1,2 Vessel oxigen 60 mmHg (Wilson 2008)
concentration (Kimura et al. 1996)
αn Normoxic cell oxygen 10−17 Mol/(c s) (Griguer et al. 2008)
consumption
αh Hypoxic cell oxygen αn/5 Mol/(c s) (Griguer et al. 2008)
consumption
Dn Diffusion coefficient for 6.6·10−12cm2/s (Tija and Moghe 2002)
normoxic cells (Wang et al. 2009)
Dh Diffusion coefficient for 10 Dn cm
2/s (Tija and Moghe 2002)
hypoxic cells (Wang et al. 2009)
DO2 Oxygen diffusion 10
−5 cm2/s (Muelller-Klieser et al. 1984)
coefficient
τnh Phenotype switch time 1 h (Jewell and Gassmann 2001)
(normoxic to hypoxic)
τhn Phenotype switch time 96 h Estimated
(hypoxic to normoxic)
τhd Cell death mean 48 h Estimated
time in anoxia
τn Normoxic cell doubling 24 h (Giese et al. 2003)
time (Berens and Giese 1999)
τh Hypoxic cell doubling 48 h (Giese et al. 2003)
time (Berens and Giese 1999)
∆O2 Sensitivity around 0.1 Mol/mm3 Estimated
transition threshold
J Oxygen exchange 0.1 cm (Mazumdar 1992)
coefficient
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2.4 Computational details
The model given by Eqs. (1) and (2) describes the dynamics of cells in the bulk
of the tumor under variable oxygenation conditions. As such, it can be studied
on any particular geometry either regular or irregular with suitable boundary
conditions and/or oxygen sources. It can also be coupled to detailed models of
tumor vasculature such as those based on phase-field models (Travasso et al.
2011) and/or combined with therapies having an oxygen-dependent effective-
ness such as radiotherapy (Jensen 2009; Vaupel 2008; Bristow and Hill 2008;
Wilson and Hay 2011).
Here, we wish to analyze our model to get insight on the formation of
necrotic areas and hypercellular regions such as those observed in gliomas. To
do so, we will stick to the simplest possible scenarios: either two dimensional
rectangular tumor geometries with vessels located on two opposite boundaries
and periodic boundary conditions on the other (opposed) two sides, or just one
dimensional sections of the previous system with oxygen flow coming from the
boundaries (end points) of a one-dimensional domain.
The sources of nutrients and oxygen in the brain are the blood vessels
which, in our 2D model, correspond to two of the four boundaries of the
tumor tissue analyzed and, in the 1D case, to two sides of the interval under
study. Here, the blood vessels are assumed to be capillaries. Exchange of gases,
nutrients, and waste materials occurs through the thin permeable walls of these
capillaries. We will denote the oxygen concentration on the two lateral blood
vessels at a given time t by Ov12 (t) and O
v2
2 (t). Oxygen flows from vessels to the
tissue to balance the different oxygen pressures, thus the boundary conditions
for the oxygen at the blood vessels are
∂O2
∂x
=
1
Ji
(Ovi2 (t)−O2), i = 1, 2. (4)
The capillary length in our model simulations is taken to be ≤ 1 mm to match
the real capillary size (Mazumdar 1992). In addition, oxygen concentration in
the capillary network does not follow the variations induced by the circulation
in the major blood vessels (Dac¸u et al. 2003). Since our computational domain
extends over a small spatial region ('700 µm in length parallel to the blood
vessels), we will assume the oxygenation to be the same independently on
the position along the capillaries as our computational domain extends over a
small spatial region (a strip of about 700 µm in length parallel to the blood
vessels).
Likewise, the oxygen exchange coefficient Ji is considered to be constant
and equal for both vessels, therefore |J1| = |J2| = J . Bearing in mind that the
average blood velocity for capillaries is around 0.1 cm/s (Mazumdar 1992) we
can estimate its value to be J ∼ 0.1 cm. Notice that our boundary conditions
(4) imply that there exists the possibility that oxygen spreads either away
from or into the vessel should the tissue oxygen concentration be lower that
or exceed the oxygen pressure at the vessel.
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Once the computational domain has been fixed, we impose the bound-
ary conditions for the cell densities to supplement model equations (1) and
(2). The following three equations represent the flux conditions describing cell
intravasation into the blood vessels
∂Cn
∂x
= − 1
Jn
Cn, (5a)
∂Ch
∂x
= − 1
Jh
Ch, (5b)
∂Cd
∂x
= 0, (5c)
Note that it is possible to calculate the number of cells that intravasate into
the blood flow for t ∈ [0, T ], T being the studied temporal window, by means
of the formula
M(t) =
∫ T
0
(JnCn + JhCh) dt, (6)
where, in general, it is to be expected that the hypoxic intravasation coefficient
Jh would be substantially larger than the normoxic one Jn, due to the higher
motility of the former cells. In metastatic processes, solid tumor cells enter
into the lymphatic and blood vessels eventually leading to the formation of
colonies in distant organs, thus Eqs. (5a) and (5b) represent the first stage of
metastasis. However, GBM only rarely metastatize out of the brain. Although
GBM cells may spread along blood vessel walls, primary brain tumors do
neither intravasate to blood vessel walls (Bellail et al. 2004) nor invade into
the bony calvarium which encloses the brain. Indeed, the capacity for vascular
invasion is a primary requisite for wide hematogenous metastasis of malignant
neoplasms. Thus, the absence of vascular invasion by primary brain tumors,
taken together with the absence of lymphatics within the brain, may explain
the observation that primary brain tumors only very rarely metastasize outside
of the brain to ectopic organs. The unique patterns of invasion and metastasis
shown by primary brain tumors suggest that these neoplasms are adapted to
the microenvironment specifically present within the central nervous system.
Therefore, we will assume henceforth that for gliomas Jn = Jh = 0. How-
ever, our model equations together with Eqs. (5), can be used in more general
contexts, e.g. to elucidate the relation between acute hypoxia or cyclic hypoxia
and metastatic processes in other types of tumors.
To solve our model set of equations with the boundary conditions on the
capillaries, plus periodic boundary conditions on the free sides, we have used
standard finite differences (second order in space) either with an explicit fourth
order Runge-Kutta method in time or an implicit second order in time Crank-
Nicholson-type scheme. Typical parameter values for the spatial step were
∆x = ∆y= 5 µm, and ∆t = 0.01 s for the explicit scheme.
In all of the simulations to be presented later we thus assume an initial
concentration of normoxic tumor cells in the region limited between two func-
tional vessels. Thus, initially the hypoxic and necrotic cell densities are zero
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for all x ∈ (0, Lx). The initial oxygen distribution is randomized with 24 mm
Hg as the mean oxygen partial pressure as described by (Vaupel et al. 1989).
Except when otherwise stated, we will assume that the vessel v1 is disrupted at
t = 0 so that v2 remains as the only functional vessel through the simulation.
3 Results
3.1 Vaso-occlusive events trigger necrosis, the formation of pseudopalisades
and vessel-cooption
We have solved our model equations (1) and (2) by including only the essential
biological facts at the cellular level allowing us to understand the formation
of palisading necrosis, and to get an insight on the sequence of events leading
to their formation as well as estimates of their lifetimes and sizes. Once the
parameters are chosen in the appropriate realistic ranges (see Table 1), the
formation of pseudopalisades does not require a detailed fine-tuning of the
parameters but it is a characteristic phenomenon arising in many of our simu-
lations. It is interesting to highlight that pseudopalisades are transient states,
being part of a sequence of events to be summarized in what follows.
In Fig. 4 we present a first scenario of the results obtained when normoxic
GBM cells are seeded close to one of two vessels located at the boundaries of
a brain tissue slice of 300 µm. Initial normoxic tumor cell density is maximum
around one of the blood vessels (colored black in the lower side of Fig. 4). The
initial conditions for this simulations are taken to be of the form Cn(x, 0) =√
1− x2/(Lx/2)2 , x ∈ (0, Lx/2] and Cn(x, 0) = 0 for x ∈ (Lx/2, Lx] with
Lx =300 µm. We assume that the brain tissue is well oxygenated until the
lower vessel is disrupted at t = 0 so that, at the outset, the hypoxic and
necrotic cell densities are zero in the whole computational domain. The results
for the evolution of the different cell densities are summarized in Fig. 4.
After the lower blood vessel undergoes a thrombus induced by the adja-
cent high density of proliferating normoxic tumor cells, these cells experience
an oxygen shortage and change their phenotype to hypoxic. This leads to an
enhanced mobility and reduced proliferation in the perivascular region in an
attempt to find a more nourishing environment to survive (Fig. 4A). A com-
plete phenotypic switch occurs in about 1 hour (see Fig. 4B) so that the new
hypoxic cells (Fig. 4C) increase their flux to the upper vessel (in red) that is
still functional, generating in the process a transient traveling wave of hypoxic
cells (see Fig. 4D where the arrow shows the direction of the movement).
Figs. 4(E,F) depict the formation of a pesudopalisade in the scale of 1 day
that develops during the subsequent days. A morphologic analysis of Figs. 4E
and F gives about 130 µm as the characteristic width value. According to Brat
et al. (2004), pseudopalisades with small widths have smaller necrotic cores.
In our case, the necrotic core is about 30 µm (Fig. 4G) and it is also formed
in the same time scale of days.
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Fig. 4 Spatio-temporal simulations showing the formation of necrotic areas sur-
rounded by hypercellular regions (pseudopalisades). Initially, normoxic GBM cells
are seeded close to the lower vessel. Pseudo color plots in A, B, C, E and G represent
normoxic, normoxic (notice the scale), hypoxic, total (hypoxic +normoxic) populations and
necrotic tissue densities, respectively. The horizontal and vertical axes correspond to time in
days (except for B in hours) and space in µm, respectively. D and F depict the normoxic and
total (normoxic + hypoxic) cell densities as a function of space for specific times indicated
in each curve and also with vertical color lines in C and E. H shows the GBM cell number
evolution with time for the different populations. At t = 0, the lower vessel suffers a throm-
bus, while the upper vessel remains fully functional during the simulation. The parameters
used in the simulations are listed in Table 1.
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Fig. 5 Initial conditions for the simulation displayed in Fig. 7. (A) Normoxic cell
density. (B) Initial oxygen distribution with 24 mmHg as the average oxygen pressure for a
healthy brain tissue (Vaupel et al. 1989).
Fig. 6 Vascular damage as a driving force for migration in Glioblastoma Mul-
tiforme. Formation of necrosis and the emergence of pseudopalisades is part of a series
of related events that are crucial for the accelerated progression of high grade astrocytic
gliomas. The development of an envelope of small scale pseudopalisades may play a relevant
role in the global migratory dynamics and invasion of these malignant gliomas driven by
vaso-occlusive events occurring at the small cellular scale, leading to the distinctive feature
in GBM of showing significant necrotic areas where frequently central vessels are present
(Brat et al. 2004).
Under persistent anoxic conditions, hypoxic cells located around the im-
paired vessel start to die (Fig. 4G). Nevertheless, there is a significant density
of migrating hypoxic cells that reach the functional vessel. Finally, Fig. 4H
illustrates the time evolution of the total GBM cell number for each popu-
lation in the full simulated tissue. It is observed that hypoxic cell number
increases significantly fast during the first hours after the thrombosis event
but then moderates its growth rate. Normoxic cell numbers have a different
growth pattern with an initial decay and a final relapse, once the functional
vessel has been co-opted. So, in less than a week, tumor cells have invaded the
300 µm of tissue.
In a second set of simulations, displayed in Figure 7, we have studied the
invasion of a tumor vessel by a pseudopalisading wave of hypoxic cells coming
from another impaired vessel. As in the previous case, a high normoxic GBM
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cell density is seeded around the lower blood vessel (see Fig. 7), but now we
assume that a small number of tumor (normoxic) cells have already migrated to
the upper blood vessel starting to colonize the second vessel (400 µm distant
from the lower vessel). The initial conditions for the tumor (normoxic) cell
density and oxygen concentrations are shown in Fig. 5 and for the normoxic
tumor cell density are given by Cn(x, 0) =
1
2 (1− tanh(x−Lx/32 )), x ∈ (0, Lx/2]
and Cn(x, 0) = 0.05(1 + tanh(
x−Lx−20
2 )) for x ∈ (Lx/2, Lx] with Lx =400 µm.
The simulation starts when the lower vessel suffers a thrombus induced
by the adjacent high density of proliferating normoxic tumor cells. The up-
per vessel is fully functional during the simulation. This vessel is completely
invaded, after 7 days, by a high tumor cell density that might induce new
vaso-occlusive events (Fig. 7A). The new hypoxic cells (Fig. 7C) generate a
transient traveling wave (Fig. 7D) where the arrow shows the direction of the
movement. Figures 7E and F show the formation of a pseudopalisade in the
time scale of one day that develops during the ensuing 7 days.
A morphologic analysis of Figs. 7E and F gives about 150 µm as the char-
acteristic width value. The necrotic core is about 60 µm (Fig. 7G) and it is also
formed in the same time scale of days. Finally, it is observed in Fig. 7H that
the hypoxic cell number increases significantly fast during the first hours after
the thrombosis event but then moderates its growth rate. Normoxic cell num-
bers have a different growth pattern with an initial decay and a final relapse,
once the functional vessel has been co-opted.
Qualitatively, it is important to underscore that this minimal model not
only reproduces the clinical observations seen in immunohistochemical anal-
ysis of histologic sections of GBM samples (Brat et al. 2004) but may also
contribute to a better understanding of the origin and evolution of those struc-
tures and to find unknown quantities such as the typical palisade lifetime or
the relationship between palisade lifetime/size and vessel distance. Moreover,
the macroscopic progression of GBM can be partially conceived, from a micro-
scopic point of view, as consisting of a large number of intravascular throm-
botic events (caused by unregulated tumor cell proliferation in the vicinity
of the vessels) giving rise to the formation and coalescence of small necrotic
foci coupled with subsequent episodes of hypoxic cell migrations in search of
nearby functional blood vessels which will eventually suffer new intravascular
thrombotic events. The envelope of many of these small-scale pseudopalisades
contributes to the high density regions on larger spatial scales as those shown
in Fig. 6.
3.2 Palisading waves leads to invasion faster than that of pure random
motion invasion
In principle, it is not clear a priori how the vaso-occlusive events relate to
the speed of the tumor invasion. Phenotypic characteristics of GBM such as
hypercoagulation, hypoxia, and abnormal angiogenesis, may be linked at the
molecular level, and hypoxia may coordinate the hypercoagulative activity of
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Fig. 7 Spatio-temporal simulations showing the formation of perinecrotic pseu-
dopalisades after a vaso occlusive event. In contrast with Figure 4, here both vessels
are initially seeded with normoxic GBM cells. After 7 days, the upper vessel is completely
invaded by a high GBM cell density and again a vaso occlusion event may occur at any
moment. All of the subplots and the rest of parameters are as in Figure 4 and the initial
data for oxygen and tumor cells are shown in Fig. 5.
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Fig. 8 Palisading waves lead to invasion faster than that by pure random motion
invasion. (A-B) Evolution of the tumor cell densities as a function of time and space
when only the upper vessel is functional while the lower vessel becomes impaired at t = 0.
Parameters are as in Fig. 4. Pseudocolor plot A depicts the total GBM cell density as a
function of time, while plot B presents density curves at various times showing the advance
of the tumor front. (C-D) Same as in plots (A-B) but when both vessels remain functional.
All parameters and initial conditions are taken as in Figure 4.
GBM cells and (protease-activated receptor) PAR-mediated angiogenic signal-
ing (Svensson et al. 2011).
On the one hand, one might naively argue that the vessel maintenance
would lead to an increased number of cells that by random motion (diffusion)
would give rise to a faster invasion due to a higher tumor cell number. On the
other hand, one might also argue that vaso-occlusive events, despite result-
ing in hypoxia, cell death and slower proliferation, could induce more mobile
cells and might instead accelerate the overall GBM progression. To gain fur-
ther quantitative insight of what is the real situation, i.e. what is the role of
vaso-occlusive events in relation with the tumor progression speeds, we have
performed a series of numerical simulations.
Fig. 8 is a representative example of our results. Subplots A,B in Fig. 8 cor-
respond to the case discussed previously where the upper vessel works normally
but the lower vessel becomes impaired due to the formation of a thrombus.
On the contrary, Fig. 8C,D shows the tumor progression when both vessels
remain functional. In the first case, the functional vessel is invaded by the tu-
mor after 8 days by a high tumor cell density (more than 45%) however when
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no thrombus is formed and both vessels stay functional (subplots C and D)
invasion becomes significantly slower; requiring 13.5 days to attain the same
tumor cell density around the upper vessel. Fig. 8 displays the coexistence of
two mechanisms driving invasion: the first one being purely diffusive and simi-
lar to that governed by a free growth (when resources are not limited) obeying
the Fisher-Kolmogorov equation, as described by (Swanson et al. 2008) and
related works. The second one shows an accelerated invasion caused by micro
thrombi formations in the tumor vessels. Thus, on the basis of our model, it
appears that vaso-occlusive events in GBM may play a key role in accelerating
the tumor invasion process through pseudopalisade formation.
Thus our model simulations suggest that the use of chemical agents slowing-
down the vessel impair might delay tumor progression in GBM patients. This
fact will be discussed throughly in Sec. 4.
3.3 There is a relation between the size of broken vessels, the palisade
lifetime and the width of the necrotic region
To further substantiate our results, we have carried out a numerical study of
the relation between the separation between a thrombotic vessel and another
functional vessel, the palisade width and its lifetime, as depicted in Fig. 9. The
characteristic width of the pseudopalisade corresponds to the dimensions of
the hypercellular region and its lifetime is the time elapsed since the palisade
is formed until it disappears. Although the standard distances between blood
vessels are in the range of 100 to 400 µm, due to the irregular and aberrant
structure of the tumor vasculature, we have considered a wider range (from 50
to 700 µm) assuming that those histologic samples showing distances larger
than 700 µm will be formed by cells for which their main oxygen source would
probably come from a vessel close to them but not visible in pathological
analyses due to its spatial arrangement.
Although our analysis correspond to one-dimensional scenarios we still
expect to get a hint on the main tendencies, since more complex higher-
dimensional scenarios with a realistic three-dimensional vessel network are
too complicated to be sistematized.
In our computational window, the distance between blood vessels equals
the tissue size and so when this is smaller than 100 µm the formation of
pseudopalisades is practically non-existent. In addition, Fig. 9 shows how the
pseudopalisade size depends on the distance between blood vessels (that may
be also expected to be roughly proportional to the vessel size), growing in a
linear fashion as the distance increases until it reaches a plateau value close
to 200 µm. Notice that vessel separations larger than 500 µm give rise to
pseudopalisades that do not experience a significant width change despite the
fact that a smaller difference between the pseudopalisade cell density and the
adjacent tissue cell density is observed in our calculations. Also, as it might be
expected, there is no appreciable necrosis until the distance between vessels is
larger than 150 µm. Then, in the range from 150 to 450 µm the necrotic core
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Fig. 9 Dependences between thrombotic-functional vessel separation, palisade
width and its lifetime. In all of our simulations GBM normoxic cells are seeded close
to the impaired vessel with a small fraction of them already invading the functional vessel.
Initial conditions are chosen similar to those of Fig. 7 and proportional to the tissue size. At
t = 0 one of the vessels becomes thrombotic while the second vessel remains fully functional
during the simulated time window. Characteristic pseudopalisade width and lifetime data
are labelled by blue triangles, and red squares, respectively. Also shown is the dependence
of the necrotic core width with the tissue size (green circles). The horizontal axis represents
the distance between blood vessels (tissue size) in µm. The vertical axes label (left one) the
palisade and the necrotic foci widths in µm; (right one) the pseudopalisade lifetime in hours.
The parameters used in the simulations are listed in Table 1.
grows exponentially and from here its growth becomes linear (Fig. 9). In other
words, if the distance from a thrombotic vessel to the nearest functional vessel
is short enough, the cells arrive to better oxygenated areas without experienc-
ing severe hypoxic stresses (thus diminishing their death) and reducing the
palisade lifetime. However, if this distance is larger than 150-200 µm (or if the
broken vessels are larger), there will be a considerable number of hypoxic cells
unable to scape from severe hypoxia giving rise to larger necrotic areas and
longer palisade lifetimes. Here again, the model although biologically simple
and solved on a simple domain, allows to explain the observed feature that
large pseudopalisades, i.e. pseudopalisades surrounding larger broken vessels
are more persistent and thus easier to observe, than small ones (cf. Fig. 9).
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4 Perspectives and Therapeutic implications
4.1 Perspectives
The model presented in this work can be extended in many ways. However
the addition of vasculature seems the more natural way providing the basis
to construct a more complex in silico framework to apply the different thera-
peutic modalities in a more realistic manner once the underlying mechanisms
involved in palisade formation have been laid down. One possibility is to main-
tain equations (1a), (1b) and (1c) respectively for the normoxic, hypoxic and
necrotic populations substituting the microscopic oxygen densities by macro-
scopic variables such as blood vessel densities or vessel functionality v(x, t)
that are to be related to the oxygenation conditions. This vessel density would
evolve according to an equation of the form
∂v
∂t
=
1
τv
VEGF(Ch, Cd)− 1
τt
THROMBOSIS(Cn). (7)
accounting for the fact that, given that space is available, hypoxic-migratory
cells Ch contribute to the generation of the new vasculature v through the
secretion of vascular endothelial grow factors (VEGF) (first term in Eq. 7)
and that normoxic cells contribute to the vaso-occlusive events (second term
in Eq. 7).
These ideas might provide a simple way to incorporate palisade forma-
tion due to micro-vascular damage to full-brain scale mathematical models
of glioma progression (Frieboes et al. 2007; Swanson et al. 2008; Bondiau et
al. 2008; Eikenberry et al. 2009; Konukoglu et al. 2010; Rockne et al. 2010;
Pe´rez-Garc´ıa et al. 2011) may allow to construct more realistic “macroscopic”
models. These models might be better suited to describe more realistically
glioma progression and incorporate the effect of therapies and as such to pro-
vide clinicians with valuable tools for treatment optimization.
Other possible extensions of our model regard the presence of a small
number of treatment-resistance (cancer-stem) cells in glioblastoma multiforme
(GBM) and whether their metabolism can be effectively targeted. Indeed, de-
termining whether this small fraction mainly depends on aerobic glycolysis
or on oxidative phosphorylation has recently been the subject of considerable
interest (Pistollato et al. 2010). It is known that in glycolytic tumors, which
is the case of high grade gliomas, oxidative phosphorylation is not completely
shut down since it provides a significant amount of ATP even under low glu-
cose requirements (Vander Heiden et al. 2009; Mathupala et al. 2010). In this
work we have focused on oxygen as one key factor known to strongly affect
GBM progression and response to treatment (e.g. radiotherapy). While our
distinction of the tumor cell phenotypes has relied on their oxic state, we an-
ticipate that, among the migratory hypoxic cells seen in the pseudopalisades,
a small fraction of them is formed by treatment-resistance cells. Actually, our
simulations suggest that during the time window where hypoxic cells migrate
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from an impaired blood vessel to a functional one any treatment critically de-
pending on the presence of oxygen will exhibit a poor clinical response. The
importance of oxygen in these subpopulations is further supported by recent
experiments by Vlashi et al. (2011) in which it was observed that in various
GBM cell lines both progenitor cells as well as those exhibiting a stem-cell-
like behavior consume less glucose and produce less lactate while maintaining
higher ATP levels than their differentiated progeny. Their conclusions were
that GBM stem cells rely mostly on oxidative phosphorylation. Even from an
evolutionary point of view, the collective migration of hypoxic GBM cells when
forming pseudopalisades appears to be a selection mechanism of the fittest cell
phenotypes.
It is necessary to underscore that perinecrotic pseudopalisades formation
in GBM is not a minor detail or yet another layer to add to the complexity
of high grade glioma growth. There is ample evidence that the formation of
necrosis and the appearance of pseudopalisades is part of a series of related
events that are crucial for the accelerated progression of high grade astrocytic
gliomas. Thus, the development of an envelope of small scale pseudopalisades
may play a relevant role in the global migratory dynamics and invasion of
these malignant gliomas driven by vaso-occlusive events occurring at the small
cellular scale, leading to the distinctive GBM feature of showing significant
necrotic areas, as observed in clinical imaging as it is exhibited in Figure 6.
On the one hand, this hystopatologic feature is a distinctive feature of
high-grade gliomas and does not arise in other types of tumors, probably due
to the very high mobility of tumor cells in astrocytoma and the low resistance
to invasion by the brain parenchyma. On the other hand, it is well known that
gliomas are very complex and heterogeneous and yet, they can be understood
in terms of two cell subpopulations corresponding to two dominant pheno-
types (DeBerardinis et al. 2007; Giese et al. 2003; Keunen et al. 2011; Onishi
et al. 2011): a population of proliferative, less mobile cells located in perivas-
cular areas and a second population of less proliferative and more mobile cells
typically infiltrating the brain parenchyma. This means that minimal math-
ematical models such as those based on Fisher-Kolmogorov type equations
accounting for GBM progression (Frieboes et al. 2007; Swanson et al. 2008;
Bondiau et al. 2008; Eikenberry et al. 2009; Konukoglu et al. 2010; Rockne
et al. 2010; Pe´rez-Garc´ıa et al. 2011) may benefit from incorporating the two
different phenotypes and necrosis as it is done in this paper.
However, in order to incorporate necrosis not only phenomenologically, as
in Pe´rez-Garc´ıa et al. (2011), but including at least some underlying mecha-
nisms, it is necessary to take into account the basic intervening steps involved
in palisade formation. In fact, to allow for the vasculature growth in response
to the pro-angiogenic factors and breakup due to vaso-occlusive events, blood
vessel dynamics must be included in the model. Moreover, oxygen variations
occur in very small spatial scales and at very fast time scales that cannot be
accounted for in detail when solving the problem at larger full-brain scales and
for times of the order of months. This means that more global models must
rely on the higher scale effective vascular density or vascular capacity m(x, t)
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rather than on oxygen. This is essential since one of the conclusions of Brat et
al. (2004) and Brat and Van Meir (2004), also supported by our simulations,
is that vascular damage is not only a key event in the formation of necrotic
areas but also a driving force for migration, and this dynamics is linked to the
evolution of the cell densities that are responsible for the vessel destruction
(normoxic cell population in the perivascular areas) and creation (hypoxic cell
subpopulations secreting VEGF and other pro-angiogenic factors).
4.2 Therapeutic implications
One of the main results of our work is the prediction that targetting vaso-
occlusive events in GBM might delay the tumor progression, a result with
relevant potential implications since GBM is a type of tumor for which even
modest survival increases are considered to be a big success because of its poor
prognosis.
Thromboembolism, i.e. vaso-occlusive events of large vessels, is well rec-
ognized as a major complication of cancer and known to be a common cause
of death in cancer patients. There is strong evidence linking venous throm-
boembolic events and malignancy. Laboratory markers of coagulation activa-
tion such as thrombinantithrombin complex or prothrombin fragments 1 +
2 support the premise that malignancy is a hypercoagulable state. Inflamma-
tory cytokines (e.g. tumor necrosis factor and interferon), coagulation proteins
(e.g. tissue factor and factor VIII), and procoagulant microparticles may be
elevated in patients with malignancy. However, the relative contribution of
chemotherapeutics, tumor cells, endothelium, and circulating procoagulants
in promoting thrombus formation continues to be investigated (Khorana and
Francis 2008; Furie and Furie 2006; Zwicker et al. 2007; Green and Kwaan
2009).
Thromboembolic complications include a broad spectrum of clinical prob-
lems, a fact that has lead to the use of thromboprophylaxis in a variety of
forms (Dolovich et al. 2000; Khorana and Francis 2008; Green and Kwaan
2009) for cancer patients. Specifically, gliomas have a high incidence of venous
thromboembolism (VTE); with several studies suggesting that 25%-30% of
these patients sustain thromboembolic events (Streiff et al. 2004; Simanek et
al. 2007). The fact that glioma cell lines secrete pro-thrombotic factors has
been known for a long time (Bastida et al. 1984) and it is also known that
the more tumoral tissue is removed during surgery of high-grade gliomas the
less-likely are the patients to die from VTE (Brose and Lee 2008; Simanek
et al. 2007). This fact has led to the consideration of thromboprophylaxis for
glioma patients, specially in subjects with higher potential risks of developing
venous thromboses (Hamilton et al. 1994; Batchelor and Byrne 2006; Jenkins
et al. 2010; Khorana and Francis 2008).
In addition to the prevention of VTE there are several direct mechanisms
of action of some anticoagulants, such as LMWH, on tumor cells: direct cell
killing (Santos et al. 2010), anti-angiogenic effects (Svensson et al. 2011) and
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many other (see e.g. Green and Kwaan 2009, Chap. 15). The results from
our model seem to imply that an additional indirect antitumoral effect from
thromboprophyylaxis might be expected related to the delay of tumor invasion,
different from the direct antitumoral effect or the increase of life expectancy
obtained from the prevention of the formation of big coagulates.
The main limitation in using LMWH in post-operative patients has been
related to the possible increase in bleeding events, that in the case of brain
surgery are potentially very harmful. However, a limited phase II clinical study
of LMWH therapies for high grade glioma patients by Robins et al. (2008) has
shown that the therapy is safe. A recent phase III trial with a small number
of patients seems to confirm this trend Perry et al. (2010).
If, as predicted, preventing capillar thrombosis induced by the tumor, re-
sults in a growth delay for the tumor, a synergistic positive effect with radiation
therapy is to be expected. Having a better oxygenation and reducing hypoxia
would lead to an enhanced tumor radio-sensitivity, that might provide an extra
benefit in survival.
Whether these predictions are clinically relevant remains to be studied, first
in animal models testing if the use of LMWH induces a significant reduction of
the formation time for palisades and delays tumor progression and, in case of
success, in more complete clinical trials. The fact that mathematical modelling
might contribute to designing therapies against such an aggressive type of brain
tumor is encouraging and we expect our work to stimulate more theoretical
and experimental studies to follow in this direction.
5 Conclusions
In this work we have put forward a simple continuous biomathematical model
allowing for the description of the formation of hypoxic hypercellular regions
around necrotic cores in glioblastoma multiforme: the so-called pseudopal-
isades. Pseudopalisading necrosis and microvascular hyperplasia are two of
the most powerful predictors of poor prognosis among invasive gliomas. Rather
than mere morphologic markers, these structures are almost certainly mech-
anistically instrumental in the accelerated growth properties that character-
ize the transition from a lower to a higher grade astrocytic glioma, such as
glioblastoma.
Our biomathematical model quantifies the migration process influenced by
the phenotypic switch of glioblastoma cells under hypoxic conditions caused
by vaso-occlusive episodes. In spite of the fact that tumor forms a three di-
mensional structure with a very complex dynamics, our numerical simulations
clearly evidence that it is possible to observe the dependence between palisade
lifetime, its necrotic core and characteristic width related to the distance from
a thrombotic to a functional vessel within a minimal mathematical model.
We have also provided quantitative metrics of the characteristic times of
formation and lifetimes of pseudopalisades after a vaso-occlusion event as well
as their width and necrosis. We stress that these important metrics are very
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challenging to measure in vivo because of the small spatial scale of the phenom-
ena involved and the fact that biopsies do not provide dynamical information
in time but only a fixed image for a given time. In addition, our results in-
dicate that smaller pseudopalisades would show shorter lifetimes and reduced
necrotic cores while larger pseudopalisades would display longer lifetimes until
reaching a threshold around the 8th day after the vaso-occlusion event. From
our calculations, pseudopalisades tend to present a characteristic width of 200
µm when blood vessel distances are larger than 500 µm (within the range
explored up to 700 µm).
Furthermore, our simulations show that palisading waves lead to a faster
invasion than that by a pure random motion invasion with unlimited resources,
implying that the mechanism of vessel break up might accelerate the glioblas-
toma progression. This suggests that targeting vaso occlusion events, probably
by means of anticoagulants such as low molecular weight heparine, or other
antithrombotic agents, might be of potential interest for therapeutics aimed
at delaying glioblastoma growth.
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